首页> 外文期刊>Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions >Comparative study on transradial approach vs. transfemoral approach in primary stent implantation for patients with acute myocardial infarction: Results of the test for myocardial infarction by prospective unicenter randomization for access sites (TE
【24h】

Comparative study on transradial approach vs. transfemoral approach in primary stent implantation for patients with acute myocardial infarction: Results of the test for myocardial infarction by prospective unicenter randomization for access sites (TE

机译:经acute动脉入路与经股动脉入路在急性心肌梗死患者初次支架植入中的比较研究:前瞻性单中心随机入路(TE)对心肌梗死的测试结果

获取原文
获取原文并翻译 | 示例
           

摘要

Transradial coronary intervention (TRI) can be performed in elective patients with low incidence of access site complications. However, the feasibility of primary stent implantation by TRI is still not clear in patients with acute myocardial infarction (AMI). We prospectively randomized 149 patients out of 213 patients with AMI within 12 hr from onset into two groups: 77 patients treated by TRI (TRI group) and 72 patients by transfemoral coronary intervention (TFI; TFI group). We compared the incidences of major adverse cardiac events (MACE; repeat MI, target lesion revascularization, and cardiac death) during the initial hospitalization and 9-month follow-up periods in both groups. There were one patient who crossed over to the opposite arm, and two patients with severe bleeding complications in the TFI group. Background characteristics of patients were similar between the two groups. The success rate of reperfusion and the incidence of in-hospital MACE were similar in both groups (96.1% and 5.2% vs. 97.1% and 8.3% in TRI and TFI groups, respectively). In selected patients with AMI, primary stent implantation by TRI is feasible as compared to TFI. Cathet Cardiovasc Intervent 2003;59:26-33.
机译:经access动脉冠状动脉介入治疗(TRI)可以在进入部位并发症发生率低的择期患者中进行。但是,对于急性心肌梗死(AMI)患者,TRI植入主要支架的可行性尚不清楚。我们从发病开始的12小时内将213例AMI患者中的149例患者随机分为两组:TRI治疗的77例患者(TRI组)和经股动脉冠状动脉介入治疗的72例患者(TFI; TFI组)。我们比较了两组初次住院期间和9个月随访期间主要不良心脏事件(MACE;重复MI,靶病变血运重建和心脏死亡)的发生率。 TFI组中有1例越过对侧手臂,而2例发生严重出血并发症。两组的患者背景特征相似。两组的再灌注成功率和院内MACE发生率相似(TRI和TFI组分别为96.1%和5.2%,分别为97.1%和8.3%)。在某些AMI患者中,与TFI相比,通过TRI进行主支架植入是可行的。 Cathet Cardiovasc Intervent 2003; 59:26-33。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号